|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.405 EUR | -0.71% |
|
-2.43% | -7.87% |
| 15/05 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
| 14/05 | Medigene Ag Maintains Earnings Guidance for 2024 | CI |
Medigene AG confirmed its financial forecast for 2022 published in the Group Management's Discussion and Analysis 2021 and continues to expect revenues of EUR 23 million - EUR 28 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.87% | 37.52M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
MEDIGENE AG 